Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparative analysis of whole-slide scanner tissue detection algorithms: Implications for scan area, scan time, and file size in high-volume digital pathology workflows.

Journal of pathology informatics·2026

Same author

Deployment of AI-driven automated quality control of whole-slide images in a large tertiary cancer center.

Journal of pathology informatics·2026

Same author

Interobserver Variability Across Whole-Slide Imaging Systems.

Archives of pathology & laboratory medicine·2026

Same author

A subset of high-grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions.

The journal of pathology. Clinical research·2026

Same author

Unintended consequences of legacy oversight in digital medicine.

Nature medicine·2026

Same author

Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?

JCO precision oncology·2026

Same journal

Update on the molecular pathology of the distinctive giant cell, fibro-osseous and bone forming lesions of the jaws.

Seminars in diagnostic pathology·2026

Same journal

Update on the molecular pathology and classification of odontogenic cysts and tumours.

Seminars in diagnostic pathology·2026

Same journal

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026

Same journal

When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses.

Seminars in diagnostic pathology·2026

Same journal

Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.

Seminars in diagnostic pathology·2026

Same journal

Recent advances in genetic predisposition to primary testicular tumors.

Seminars in diagnostic pathology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Primary malignant bone tumors--recent developments.

Meera Hameed¹, Howard Dorfman

¹Department of Pathology, Memorial Sloan-Kettering Cancer Center, Weill College of Medicine of Cornell University, New York, New York 10065, USA. hameedm@mskc.org

Seminars in Diagnostic Pathology

|June 17, 2011

Summary

This summary is machine-generated.

Primary malignant bone tumors are rare. This review covers recent advances in understanding the molecular causes of common bone cancers like osteosarcoma and Ewing sarcoma, improving patient outcomes.

More Related Videos

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Related Experiment Videos

Last Updated: Jun 1, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Area of Science:

Oncology
Pathology
Genetics

Background:

Primary malignant bone tumors are rare sarcomas, accounting for <0.2% of US cancer diagnoses.
Diagnosis and management necessitate a multidisciplinary team including surgeons, radiologists, pathologists, and oncologists.
Current 5-year survival rates for osteosarcoma and Ewing sarcoma are 70% and 60%, respectively.

Purpose of the Study:

To summarize recent developments in the molecular pathogenesis of common primary malignant bone neoplasms.
To highlight advances in understanding the underlying biological mechanisms of these rare cancers.

Main Methods:

Literature review of recent studies on molecular pathogenesis.
Synthesis of current knowledge on genetic and molecular alterations in bone sarcomas.
Analysis of treatment modalities and their impact on survival rates.

Main Results:

Identification of key molecular pathways implicated in osteosarcoma and Ewing sarcoma development.
Understanding of genetic mutations and epigenetic modifications driving tumor progression.
Correlation between molecular insights and therapeutic strategies.

Conclusions:

Advances in molecular pathogenesis offer new targets for therapy.
A comprehensive understanding of molecular mechanisms is crucial for improving survival rates of primary malignant bone tumors.
Continued research into molecular pathways will drive future treatment innovations.